U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) Director Nancy Ham sold 600 shares of the firm's stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $81.71, for a total value of $49,026.00. Following the completion of the sale, the director directly owned 1,994 shares of the company's stock, valued at $162,929.74. This trade represents a 23.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
U.S. Physical Therapy Trading Down 1.3%
Shares of USPH traded down $1.00 during midday trading on Tuesday, reaching $78.30. The company had a trading volume of 88,967 shares, compared to its average volume of 116,072. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The stock has a market cap of $1.19 billion, a PE ratio of 34.19, a price-to-earnings-growth ratio of 3.97 and a beta of 1.47. The firm has a 50 day simple moving average of $80.01 and a 200-day simple moving average of $76.46. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping analysts' consensus estimates of $0.71 by $0.10. The business had revenue of $197.34 million during the quarter, compared to analysts' expectations of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The company's revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.73 EPS. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.45 per share. The ex-dividend date was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.3%. U.S. Physical Therapy's dividend payout ratio is currently 78.60%.
Hedge Funds Weigh In On U.S. Physical Therapy
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Assetmark Inc. boosted its holdings in U.S. Physical Therapy by 35.7% during the 2nd quarter. Assetmark Inc. now owns 570 shares of the company's stock valued at $45,000 after acquiring an additional 150 shares during the period. Portside Wealth Group LLC boosted its holdings in U.S. Physical Therapy by 3.9% during the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock valued at $297,000 after acquiring an additional 154 shares during the period. Osaic Holdings Inc. boosted its holdings in U.S. Physical Therapy by 1.6% during the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company's stock valued at $817,000 after acquiring an additional 166 shares during the period. Police & Firemen s Retirement System of New Jersey boosted its holdings in U.S. Physical Therapy by 5.7% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 3,247 shares of the company's stock valued at $254,000 after acquiring an additional 176 shares during the period. Finally, Precision Wealth Strategies LLC boosted its holdings in U.S. Physical Therapy by 6.6% during the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock valued at $221,000 after acquiring an additional 189 shares during the period.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on USPH shares. Wall Street Zen upgraded U.S. Physical Therapy from a "hold" rating to a "buy" rating in a report on Saturday. Barrington Research increased their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Finally, Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, U.S. Physical Therapy has an average rating of "Moderate Buy" and a consensus target price of $110.25.
Check Out Our Latest Research Report on U.S. Physical Therapy
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.